Mustef (Dimethyl Fumarate)

Dimethyl fumarate activates the Nrf2 signaling pathway, which up‑regulates antioxidant and cytoprotective genes. This reduces oxidative stress and inflammation, leading to modulation of immune responses. The resulting anti‑inflammatory effect helps limit neuroinflammation in multiple sclerosis and decreases keratinocyte proliferation in psoriasis.

The specific dose of Mustef is determined by the prescribing healthcare professional based on the individual patient's condition, disease severity, and response to therapy. Physicians follow approved dosing guidelines and may adjust the regimen according to clinical monitoring and tolerability.

Safety data for dimethyl fumarate in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider.

To place an order, submit an enquiry on the Mustef product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mustef (dimethyl fumarate) is a disease‑modifying therapy that primarily modulates the immune system via the Nrf2 pathway, offering oral administration. Compared with injectable or infusion therapies, it provides a convenient oral option with a distinct safety profile, though individual efficacy and tolerability vary and should be evaluated by a neurologist.

Mustef should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Mustef is taken orally, usually with food to reduce gastrointestinal discomfort. The tablets (or capsules, if applicable) are swallowed whole with a full glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional and not alter the regimen without medical advice.

The most serious risks include severe lymphopenia, which can increase susceptibility to infections, and the rare but potentially fatal progressive multifocal leukoencephalopathy (PML). Liver injury and severe skin reactions such as Stevens‑Johnson syndrome are also rare but serious adverse events that require immediate medical attention.

Mustef is contraindicated in patients with known hypersensitivity to dimethyl fumarate or any of its excipients. It should be avoided in individuals with active infections, those receiving live vaccines, and patients with severe hepatic impairment. A thorough medical evaluation is essential before initiating therapy.